Consumer data company Asa Ren, UAE-based G42 Healthcare teaming up to support Indonesia’s national genome program
Asa Ren, a consumer DNA data company and AI technology company G42 Healthcare based in the UAE has established a strategic partnership to support Indonesia’s national genomic projects.
Asa Ren has an end-to-end DNA genotyping platform for wet lab and bioinformatics services, which is being offered to hospital groups, clinics and healthcare companies, while G42 Healthcare has built built the Omics Center of Excellence, which has become the backbone of the Emirati Genome Program, the UAE’s population genomics initiative.
WHY IT IMPORTANT
According to the press release, they will help develop and enhance the country’s genome sequencing and bioinformatics capabilities using microarray and whole-genome sequencing (WGS) methods. Their collaboration will support the Indonesian Ministry of Health’s Biomedical Genome Science (BGSi) Initiative, which aims to develop a more precise treatment for key diseases.
They also intend to work on joint proposals to develop and expand Indonesia’s electronic medical passport, telehealth and health data analysis, as well as build a biobank. genomics can accelerate personalized healthcare in the country.
BIGGER BACKGROUND
Earlier this year, Indonesia identified genomics as one of the six pillars of its healthcare transformation strategy.
To support this, BGSi was launched in August with the aim of establishing a reliable population database of 10,000 whole genomes over the next two years. This database will be used to support the development of treatments for six major diseases – cancer, infectious diseases, degenerative brain and neurological diseases, metabolic diseases, genetic disorders and aging. chemical.
The program is being implemented at seven hospitals: Dr Cipto Mangunkusumo Hospital, National Brain Center Hospital, Rumah Sakit Penyakit Infeksi Sulianto Saroso, Persahabatan Central General Hospital, Dharmais Cancer Hospital, General Hospital Dr Sardjito and Professor IGNG Ngoerah Hospital.
MGI Tech Co., a manufacturer of clinical high-throughput gene sequencing machines based in Shenzhen, has been selected as one of the technology suppliers for the program. Together with local partner PT Bakti Energi Abadi, it will create a total workflow based on ultra-high throughput gene sequencing DNBSEQ-T7RS, MGISP-960RS and MGISP-NE384RS automated systems as well. like the ZTRON data platform.
